60
Solve Therapeutics, Inc. raises $50.4M under Reg D
Company raise · Raising · Offering $75.6M · Sold $50.4M · BELMONT, CA · filed 2024-12-26
55
Solve Therapeutics, Inc. raises $48.2M under Reg D
Company raise · Raising · BELMONT, CA · Form D filed 2025-11-25
$50M+ raise
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
People on the filing
| Daniel D. McHugh | Director |
| Langdon Miller | Executive Officer |
| David Johnson | Executive Officer, Director |
| Clayton D. Knox | Executive Officer |
| Robert D. Mittendorff | Director |
| Alan Colowick | Director |
| Jason Pitts | Director |
| Peter Colabuono | Director |
Signed by David Johnson, Chief Executive Officer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.